Daxor ROE 2010-2011 | DXR

Current and historical return on equity (ROE) values for Daxor (DXR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Daxor ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2011-12-31 $-0.01B $0.04B -14.46%
2011-09-30 $0.00B $0.04B -6.78%
2011-06-30 $0.00B $0.05B 8.56%
2011-03-31 $0.00B $0.05B 8.70%
2010-12-31 $0.01B $0.05B 10.81%
2010-09-30 $0.00B $0.05B 4.30%
2010-06-30 $0.00B $0.04B 4.26%
2010-03-31 $0.01B $0.05B 16.84%
2009-12-31 $0.01B $0.05B 13.71%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.053B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.021B 19.13
Encompass Health (EHC) United States $11.999B 23.97
DaVita (DVA) United States $9.630B 13.77
Elanco Animal Health (ELAN) United States $8.848B 19.79
Chemed (CHE) United States $6.563B 21.98
RadNet (RDNT) United States $5.262B 190.03
Option Care Health (OPCH) United States $4.630B 19.81
Amedisys (AMED) United States $3.321B 21.26
Addus HomeCare (ADUS) United States $2.141B 23.08
LifeStance Health (LFST) United States $2.011B 0.00
Astrana Health (ASTH) United States $1.661B 58.10
Aveanna Healthcare Holdings (AVAH) United States $1.494B 27.50
U.S Physical Therapy (USPH) United States $1.346B 33.66
Pennant (PNTG) United States $0.901B 31.81
Atai Life Sciences (ATAI) Germany $0.811B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.060B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00